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Message from the Vice President, Aurora Cancer Care
During my many years of practice
as a surgical oncologist with special
interest in pancreas and hepatobiliary
surgery, I was often asked what was
the essence of surgical oncology.
My response was simple: “A surgical
oncologist is a surgeon who knows
when not to operate on cancer.”
I am delighted that Aurora Cancer
James Weese, MD, FACS
Vice President,
Care (ACC) has a program that truly
Aurora Cancer Care
embodies this concept—surgeons,
medical oncologists, radiation
oncologists and interventional oncologists working as a team
to combine all of the cancer modalities to provide patients
the best evidence-based care that gives the greatest chance
for cure while maintaining the best quality of life and function.
Aurora Cancer Care provides this for over 8,000 new cancer
patients per year. With our recent merger with Advocate
Health Care to form Advocate Aurora Health, we will jointly
care for over 17,000 new cancer patients each year. With our
close working relationship with Advocate’s Cancer service
line leadership, we are looking to take the best practices
from both organizations and establish them as standards
across our much larger combined footprint. Advocate will
be transitioning to the EPIC platform for their electronic
medical record. This will enable our Illinois colleagues to
take advantage of the VIA Oncology pathways which have
been so successful at Aurora in decreasing variation in care,
decreasing ER utilization for cancer patients, and reducing
costs while providing the best of care. Advocate should have
this capability by mid-2019 and their oncologists are anxious
to have these important tools available for their patients.

ACC has been the recipient of a National Cancer Institute
NCORP grant, which allows us to bring innovative clinical
trials to our patients in their home communities. In the fifth
year of our grant we are adding some of the Advocate sites
to be able to expand our ability to reach an even larger
group of cancer patients. By the addition of VIA and the
NCORP grant, our clinical trials volumes have increased by
nearly 400 percent in the last four years. We expect to see
even greater growth with the addition of Advocate sites and
will incorporate them fully when our renewal application is
submitted later this year.
Education is critical when working at the front line of cancer
care. Aurora’s 6th annual best of ASCO CME conference in
August 2018 attracted nearly 200 cancer physicians and
other team members—the largest audience of this very
successful program. On October 13, we will present the first
Advocate Aurora CME program, providing the current state
of screening focused on a primary care audience. We will
continue to increase these activities with our new partners in
the future.
Continuing the current value of education, our first surgical
oncology fellow, Dr. Geoffrey Bellini, started this month.
Under the direction of Drs. Aaron Chevinsky and Wesley
Papenfuss of surgical oncology, Dr. Bellini will not only go
through a curriculum helping him to gain expertise in all
aspects of cancer surgery, but also receive training in medical
oncology, radiation oncology, interventional oncology,
pathology, and a number of the important areas that support
successful cancer treatment.
We appreciate your support in helping Aurora Cancer Care
to grow. This wouldn’t be possible without the participation
of our many patients who allow us to be part of their
cancer journey. ■
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By Scott Feist, Aurora Integrative Medicine Manager

More than ever, patients at Aurora

Cancer Care clinics are taking advantage
of supportive care treatments such
as massage therapy, acupuncture,
aromatherapy and Reiki. Requests for these
services continue to grow and Aurora is
responding. Aurora Integrative Medicine
offers holistic solutions on-site at 17 of the
19 Aurora Cancer Care clinics across eastern
Wisconsin. Patients receive massage
therapy, Reiki and aromatherapy during
chemotherapy treatments, and acupuncture
adjacent to other appointments. Integrative
practitioners are part of the health care
team and care coordination.
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team members. Aurora patient Denise
Gillmore recently wrote: “I wanted to let you
know how important the massages I receive
are to my healing and even survival. In part
because [Kristine Besharat, LMT] dedicates
herself to just that with each and every
individual that receives her treatments.”
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Integrative Therapies Bring Cancer Care
to the Next Level

Denise went through years of cancer
treatments. Her first round of chemotherapy
was prescribed for three days a week for
several months. In her letter, she went on
to say, “I believe that the massages I’ve
received are a big part of my success. I’ve
spent a lot of time immobile and yet the
feeling, coldness and numbness of my legs
and feet is much improved and so much
more. My spirit’s much better when I get my
massage! Thank you! I would hope that you
not only continue the massage program but
expand it.”

Aurora Integrative Medicine Results
Denise is not the only patient who has
benefitted from integrative medicine.
Aurora Integrative Medicine has been
collecting data to demonstrate our positive
impact on patients. In the first quarter
of 2018, 931 acupuncture treatments,
986 massage treatments and 303 Reiki
treatments were delivered to patients at
Aurora Cancer Care clinics.

Patients Report:
Massage
Therapy

Acupuncture
54%

PAIN

42%

63%

STRESS

54%

This patient-reported feedback helps to
paint the picture that providing access
to hands-on natural care, in combination
with proven and innovative treatments in a
multidisciplinary setting, gets better results.
It is our aim to expand integrative services
and provide even more personalized,
whole-person care. You can help to provide
massage, acupuncture and aromatherapy
to cancer patients by donating to the
Aurora Foundation at give.aurora.org/
cancer and selecting AF Aurora Cancer
Care Integrative Therapies Fund. ■

Team Phoenix Completes Record Setting Season
By Ilka Hoffins, Team Phoenix Program Director, Aurora Cancer Care

Huge congratulations to Team Phoenix 2018. For the

first time in the eight-year history of Aurora’s Team
Phoenix program, all 51 cancer survivor athletes that
started this year’s 14-week triathlon training program
became triathletes by completing a sprint distance
triathlon on July 31—a very rewarding accomplishment for
this year’s athletes, medical staff, coaches and volunteers
and in particular program founders and medical directors,
Judy A. Tjoe, MD, FACS, and Leslie J. Waltke, PT, DPT,
as well as Team Phoenix medical director, Michael P.
Mullane, MD.
The 2018 Team Phoenix group represented a diverse
population of athletes. Ranging in age from 31 to 69 with
a variety of forms and stages of cancer (breast, ovarian,
brain, gallbladder, colon and lymphoma), women came
from all over the Milwaukee metro and Kenosha areas
to train together. The athletes started the season with
varying degrees of ability, from those that had never been
in open water over their ankles and had limited experience
on a bike to women who have completed marathons. All
athletes were welcomed and trained side by side for the
triathlon, which included a quarter-mile swim followed by
a 15-mile bike ride and finished with a 5k run/walk.
The athletes’ courageousness, determination and
commitment, in combination with the contracted
professional triathlon coaches and donated time from
Aurora’s medical directors and clinicians, along with 80
alumnae volunteers helped set the season up for success.
Another factor that led to this year’s success was the
outstanding community support, including a generous
donation (used for training and equipment such as heart
rate monitors and watches) from the Vince Lombardi

Cancer Foundation, a bike-loan program provided by
Wheel and Sprocket, complimentary swim suits provided
by Lands’ End, gym and pool access provided by
Xperience Fitness, and individual donations through the
Aurora Health Care Foundation.
In collaboration between the Aurora Research Institute
and Marquette University, many of the 2018 Team Phoenix
athletes participated in a research study exploring the
physiological, psychological and motivational aspects
of team triathlon training for cancer survivors. Historic
research collaboration between Marquette University and
Aurora’s Team Phoenix athletes has led to opportunities to
present at national conferences, and this summer one of
these research papers won the “Midwest Nursing Research
Society/Western Journal of Nursing Research Best Faculty
Paper Award for 2018.”
The 2018 Team Phoenix athletes and leadership team are
excited about this year’s accomplishments and looking
forward to continuing their new lifelong friendships and
fitness habits as they continue to redefine “survivorship.”■

As one athlete put it ...
A year ago (August 2017) I was 317 pounds,
walked with a cane, had a knee brace and
debilitating back pain. In January (2018) I was
treated for breast cancer. Today (August 2018)
I’m 198 pounds, swam a quarter mile, biked
15 miles, and walked 3 miles. TODAY I AM A
TRIATHLETE. I am Strong, Proud, Alive
and Redefined. I AM TEAM PHOENIX.

We are all enthusiastically
looking ahead to recruit
Team Phoenix 2019.
If you know a cancer survivor who
would like to take part in this life
changing training and research
program that combines medically
overseen and professionally coached
training sessions with the camaraderie
of group exercise, please have them
contact program director, Ilka
Hoffins, at teamphoenix@aurora.org.
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Low-Dose Lung Cancer Screening
By Anne Weers, RN ,MS, Director Clinical Program Quality, Aurora Cancer Care

Lung cancer is the No. 1 killer in America for both men

and women, taking more lives than colon, breast and
prostate cancer combined. Every year, 200,000 Americans
are diagnosed with lung cancer and 160,000 die from it.
However, low-dose CT lung screening can reduce lung
cancer-specific mortality by 20 percent.
The goal of lung cancer screening is to enable detection
of lung cancer before it has spread. Treatment can then be
provided, which may reduce the likelihood of dying from
lung cancer as screening increases the five-year survival
rate for stage 1 lung cancer to nearly 90 percent.
Low-dose CT (LDCT) lung cancer screening is being
conducted at nine credentialed sites throughout the
Aurora Health Care system. While some sites have had
active programs longer, most have been in place since
2015. It was at this time when Medicare, ACA and
most insurance companies covered the cost of
screening for high-risk patients who meet the
following eligibility criteria:
• Age 55 to 77 years old.
• Have a 30 “pack year” or greater history. (Pack years
are calculated using the number of years smoked times
the amount of packs of cigarettes smoked each day.
For instance: 1pack/day for 30 years is 30 pack years; 2
packs/day for 15 years is 30 pack years.)
• Are current smokers or former smokers who have quit
in the past 15 years.
• Have no current symptoms of lung cancer such as
coughing up blood or sudden weight loss.

The screening is an easy, unobtrusive test that takes less
than 10 seconds. No medications are given, and no needles
are used. Patients can eat before and after the exam.
They are not required to remove their clothes, unless their
clothing contains metal on the chest. Patients must be
able to hold their breath for at least six seconds while the
chest scan is being taken.
We look to the patient’s primary care physician, who is
the preventive care expert who routinely discusses the
risks and benefits of a variety of screening choices with
their patients, including the LDCT lung screen. A Best
Practice Alert (BPA) for the LDCT lung screening was
initiated in the patient electronic medical record in May
of 2017. This has armed physicians with knowledge about
the eligibility criteria and recommendations to support the
shared decision-making process with high-risk individuals
considering enrollment in a lung-screening program.
The following includes the LDCT lung screening cases
completed and the cancer detection rate at the nine
credentialed Aurora Medical Center sites for 2016 and
2017. The cancer detection rate of 1.5 percent is in
alignment with the national average. Of those cases that
detected lung cancer, 59 percent of them were identified
as early stage lung cancer. Treatment for early stage
lung cancer is curative intent—the goal being to cure
the disease. To treat early stage lung cancer, surgery or
radiation therapy may be all that is needed. ■

2016/2017 Aurora Health Care LDCT Lung Screening Volume
Aurora Site

2016

2017

2016/2017 Change

Cancer Detection Rate

St. Luke’s

417

1469

252.3%

1.8%

Green Bay

294

435

48%

1.8%

Manitowoc

130

274

110.8%

1.5%

Lakeland

140

287

105%

0%

Kenosha

302

692

129.1%

1.3%

Oshkosh

108

374

246.3%

0.5%

Summit

172

306

77.9%

2.3%

Grafton

252

603

139.3%

2%

Sheboygan

34*

254

647.1%

0.4%

1849

4694

153.9%

1.5%**

Aurora Total
** Corresponds to National Average
* start 10/2016
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National Cancer Institute’s (NCI)
Community Oncology Research Program update
By Neha Glandt, Research Program Administrator, NCORP

Aurora Health Care is in its fifth year as a member of

the National Cancer Institute (NCI) Community Oncology
Research Program (NCORP). Aurora NCORP is one of 34
program sites in the nation bringing NCI-sponsored clinical
trials directly to patients in the community.
NCORP offers a range of clinical studies focusing on a
variety of cancer types and specialties. “The purpose of
the program is to allow a more diverse patient population
to participate in studies in ‘real world’ health care settings
close to home,” said Dr. Michael Thompson, co-principal
investigator for Aurora NCORP. “This expanded access to
clinical trials generates more broadly applicable evidence
that can improve patient outcomes and reduce cancer
disparities.”
Understanding and Predicting Breast Cancer Events
After Treatment (UPBEAT)
As part of the program, Aurora Health Care is the fifth
health care organization in the nation to enroll participants
in a clinical trial recruiting breast cancer patients and
healthy, cancer-free participants. The observational
study will evaluate whether chemotherapy for breast
cancer affects the heart and the ability to exercise, as
well as fatigue.
Sponsored by Wake Forest University Health Sciences
NCORP Research Base and the NCI, the research trial,
“Understanding and Predicting Breast Cancer Events
After Treatment” (UPBEAT) will enroll 840 participants
with Stages I, II and III breast cancer and 160 healthy
participants. All Aurora cancer clinics are enrolling
patients. The actual testing will take place at the
Aurora St. Luke’s Medical Center.
“This is a rare clinical trial in which family and friends of
those diagnosed with the disease being studied can play
a larger supportive role by also participating in research,”
said Randall Lambrecht, PhD, senior vice president
of Aurora Health Care and president of Aurora
Research Institute.
Early detection and treatment of breast cancer has
improved five-year survival rates for people with breast
cancer to 90 percent. However, studies have shown
that initial lifesaving chemotherapy may increase risk of
exercise intolerance, fatigue and long-term heart problems,
including heart failure.

Early detection and treatment of
breast cancer has improved fiveyear survival rates for people with
breast cancer to 90 percent.

“We risk losing the incredible progress made in survival
rates for women with breast cancer due to the emergence
of these cardiovascular complications in cancer survivors,”
said Thomas Saphner, MD, oncologist and principal
investigator for this trial. “Studies like this will help us
understand the causes of heart complications following
cancer treatment, with the ultimate goal being the
development of therapies to prevent future heart problems
in cancer survivors.”
Researchers will compare the results of the healthy
participants against those who received non-anthracycline
chemotherapy and anthracycline chemotherapy. They will
assess the relevance of pre-existing cardiovascular disease
risk factors—such as age and race, a history of smoking,
hypertension, diabetes or coronary artery disease,
medications, and physical activity—as well as modifiable
risk factors—such as body mass index, blood pressure,
psychosocial factors and lifestyle behaviors—on the
study outcomes.
The study is open to qualifying patients and requires
two to three cardiac scans and a total of five visits to
Aurora St. Luke’s Medical Center that include blood tests
and questionnaires over a two-year period. Subjects
participating in this study are compensated for their time.
Individuals interested in participating in UPBEAT should
contact Karen Cheek at (414) 778-4345 or
karen.cheek@aurora.org.
“One in every four patients diagnosed with cancer in
Wisconsin is seen at an Aurora Cancer Care facility,” said
Dr. Saphner, co-principal investigator of Aurora NCORP.
“We will take advantage of our sophisticated cardiac
imaging capabilities to improve the cardiac outcomes of
the cancer patients we serve.”
Patients interested in learning more about all NCORP
trials should speak with their health care provider or visit
aurora.org/ncorp. ■
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Aurora Cancer Care Celebrates Pride
By Jennifer Jarvey Balistreri, MS and Chris Hogue, Aurora Cancer Care

June is designated as international lesbian, gay,

bisexual, transgender and questioning or queer (LGBTQ+)
Pride month. The purpose of the commemorative
month is to recognize and honor the impact, struggles
and perseverance that LGBTQ+ individuals have had
within many aspects of history—locally, nationally and
internationally. In Wisconsin, Milwaukee and Kenosha
celebrate Pride month every year with a Pride celebration
festival and parade annually.
Health care is often an area the LGBTQ+ community feels
less embraced due to various anxieties about acceptance.
This perception can then trigger lower participation in
preventive screening, follow-up and routine care within
this population. According to the National Cancer Institute
(NCI), in addition to national guidelines of prevention
and screening, cancer surveillance also includes the
assessment of environmental and behavioral cancer risk
factors, screening practices, and the quality of care across
the cancer care continuum. The LGBTQ+ community is a

approximately 30 blood pressure screens, 20 oral cancer
screens and just over a dozen clinical breast exam
screens. Aurora’s clinical team in Kenosha provided 14
oral cancer screenings at Kenosha’s PrideFest. There was
one abnormal oral cavity exam and one abnormal axillary
lymph node found within the breast cancer screenings.
All participants were provided with forms containing
exam results and encouraged to follow up with medical
providers as needed. They were also given information on
access to various primary care options in the area if
they did not have an established provider to follow up
with directly.
Prior to Milwaukee PrideFest, Aurora Cancer Care,
along with other local LGBTQ+ and allied organizations,
presented a joint letter to the Milwaukee Pride board
asking them to decline sponsorship dollars from big
tobacco this year. This is a reflection of the overall goal of
creating a healthier LGBTQ+ community. The outcome was
successful, as Milwaukee PrideFest will no longer be taking
sponsorship dollars from tobacco companies.

The outcome was successful as
Milwaukee PrideFest will no longer
be taking sponsorship dollars
from tobacco companies.

unique subpopulation to these additional variables and has
a clear need for further outreach due to the lack of cancer
screening and perceived lack of support and acceptance.
Aurora Cancer Care, teamed up with Diversity & Inclusion
and Talent Acquisition, was able offer a local connection to
LGBTQ+ health care access through participating in both
the Milwaukee and Kenosha Pride wellness celebrations
this year. At each event, our team members and providers
were able to expand cancer screening and education to
LGBTQ+ community in various ways.
Our participation at Milwaukee Pride included providing
free breast and oral cancer screenings. This was the first
time within the health and wellness area that cancer
screening was provided. Additionally, we conducted
blood pressure screening as a continued wellness benefit.
In Milwaukee, our clinical team members performed
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Kenosha Aurora team members also educated participants
on the effects of smoking with the lung display. This
display shows a healthy lung and a simulated pack a
day 20-year smoker’s lung, which provided folks with
a visual understanding of how smoking can damage
lung tissue and shows the difference in lung expansion
during respirations. This demonstration contributed to
the importance of Aurora Health Care’s low-dose CT lung
cancer screening program.
There was an overall continued positive response to
Aurora Cancer Care’s presence at both Pride celebrations
from participants and fellow employees. We were able to
engage in many conversations about cancer prevention,
screening, survivorship and overall wellness. We continue
to support the LGBTQ+ community throughout the year
and annually at Pride events.■

Welcome New Cancer Care Providers
Dheeraj Reddy, MD, is a firm believer in patient empowerment and informed decision making.
He strives to build trust with his patients through honesty, compassion and clear communication.
Dr. Reddy provides both inpatient and outpatient consultations with comprehensive care plans for
patients with various oncologic and benign/malignant hematologic conditions. He accepts and
manages all consult diagnoses but has a special interest in thoracic and GI oncology.

Dheeraj Reddy, MD
Hematology and
Oncology

Dr. Reddy earned his medical degree at the University of Guyana Faculty of Health Sciences. He
completed his residency in Internal Medicine at Southern Illinois University and his fellowship in
Medical Oncology at East Tennessee State University. He is board certified by the American Board
of Internal Medicine.
In his free time, Dr. Reddy enjoys traveling internationally, hiking, photography, reading and
playing tennis.
To learn more or to refer a patient, contact Aurora Cancer Care- Mayfair South, 1055 N. Mayfair Rd.
Wauwatosa at 414-476-8450 or Aurora Cancer Care- West Allis at 414-329-5950.
Brent Witten, MD, has a practice philosophy that the needs of his patients come first.
Dr. Witten provides diagnosis and treatment of benign, malignant and metastatic tumors of
bone and soft tissue for adults and pediatric patients. He is trained in limb preservation surgery,
performs bone and soft tissue tumor removal and stabilization for impending pathologic fractures.
Additionally, Dr. Witten treats hip and knee arthritis and performs joint replacement surgery.

Brent Witten, MD
Orthopedic Surgery/
Musculoskeletal
Oncology

Dr. Witten earned his medical degree from Wake Forest University School of Medicine in WinstonSalem, North Carolina. He completed his residency in orthopedic surgery at West Virginia University
in Morgantown, West Virginia, and his fellowship in musculoskeletal oncology at the Mayo Clinic in
Rochester, Minnesota.
Dr. Witten is married with two boys. Outside of work he enjoys spending time with family and being
outdoors camping and backpacking.
To learn more or to refer a patient, contact Aurora Orthopedics- Aurora Medical Center Grafton at
262-387-8300 or Aurora Orthopedics- St. Luke’s Medical Center at 414-649-7900.
Meredith Witten, MD, believes in a team approach to patient care. From the start, Dr. Witten wants
her patients to feel comfortable asking questions and to know that she is there for them every
step of the way. Breast cancer treatment involves a multidisciplinary team and necessitates good
communication among treating physicians and the patient.

Meredith Witten, MD
Breast Surgical
Oncology

As a breast oncology surgeon, Dr. Witten performs lumpectomy, partial mastectomy, skin-sparing
mastectomy, nipple sparing mastectomy, total mastectomy, oncoplastic breast reconstruction
and port placement. Research is an essential part of ensuring that treatments move forward, so
Dr. Witten believes it is important to know current trials and different patient options to provide
the best care.
Dr. Witten earned her medical degree at Wake Forest University School of Medicine in WinstonSalem, North Carolina. She completed her residency in General Surgery at Allegheny General
Hospital in Pittsburgh, Pennsylvania, and her fellowship in Breast Surgical Oncology at the University
of Alabama at Birmingham. She is board certified by the American Board of Surgery.
In her free time, Dr. Witten enjoys baking, cooking, exercise classes (cycling and Zumba), traveling
and spending time with her family.
To learn more or to refer a patient, contact the Aurora Comprehensive Breast Care Centers at Aurora
St. Luke’s Medical Center at 414-385-2301 or Aurora Sinai Medical Center at 414-219-6809.
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This October marks
the 10th anniversary
of Pink Possible!
By Sarah Tomczyk, Donor Stewardship Coordinator,
Aurora Health Care Foundation–Cancer Team

Nationally, one out of eight women will hear the words, “You have breast cancer,” in
her lifetime. Last year, roughly one-third of the women in Wisconsin who were newly
diagnosed with breast cancer chose Aurora Cancer Care for their care.

This year, we celebrate the 10th anniversary of the Pink Possible fundraising campaign,
which has helped raise breast cancer awareness in our communities and enhance care
for Aurora Cancer Care patients and their families.
Dawn Panfil, a breast cancer survivor, started the Pink Possible movement by offering
pink hair extensions at her salon. In 2017, thanks to the campaign started by Dawn,
$64,000 was raised across our system, and the effort continues to gain momentum.
But this campaign is not just about raising funds and enhancing care—it’s also about
celebrating survivorship. This year, to mark a decade of this effort, survivors are invited
to attend the Party for a Purpose— a survivorship celebration through the decades.
Panfil, who will receive special recognition at Party for a Purpose, said, “It’s wonderful to
be able to reach out to women who are on the same road. There is life beyond cancer.”
The funding received for Pink Possible enhances educational programs, events,
prevention, resources and survivorship resources at Aurora Health Care.
One month. One cause. Many ways to help.
Party for a Purpose is one of the many ways you can
support Pink Possible this month.
To learn more about all of the great Pink Possible
events in the community, go to give.aurora.org/
pinkpossible. ■
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Did you
know?

The merger of Advocate Aurora
Health created the 10th largest
not-for-profit hospital system
in the country with a revenue
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including 3,000 physicians, and
operate more than 500 sites of
care, including 27 hospitals.
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